Hussman Strategic Advisors’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-105,000
Closed -$897K 298
2024
Q4
$897K Buy
+105,000
New +$897K 0.26% 147